Vera Therapeutics, Inc.
NASDAQ:VERA
49.43 (USD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||||
| Current Assets: | |||||||||||||||||
| Cash & Cash Equivalents
| 27.256 | 25.085 | 69.105 | 45.681 | 27.441 | 33.889 | 137.385 | 43.459 | 30.475 | 50.427 | 111.506 | 79.674 | 86.191 | 91.625 | 49.505 | 53.654 | -3.229 |
| Short Term Investments
| 326.053 | 359.302 | 334.559 | 115.035 | 132.498 | 147.132 | 59.768 | 71.194 | 83.945 | 81.501 | 39.432 | 0.867 | 0.057 | 0.085 | 0.067 | 0.086 | 6.458 |
| Cash and Short Term Investments
| 353.309 | 384.387 | 403.664 | 160.716 | 159.939 | 181.021 | 197.153 | 114.653 | 114.42 | 131.928 | 150.938 | 79.674 | 86.191 | 91.625 | 49.505 | 53.654 | 3.229 |
| Net Receivables
| 0 | 1.96 | 1.631 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.879 | 0.472 | 0 |
| Other Current Assets
| 10.822 | 8.4 | 11.075 | 11.307 | 11.681 | 9.593 | 7.296 | 11.045 | 10.562 | 10.41 | 6.805 | 2.863 | 3.569 | 4.251 | 2.027 | 0.607 | 0 |
| Total Current Assets
| 364.131 | 389.503 | 407.923 | 165.543 | 171.62 | 190.614 | 204.449 | 125.698 | 124.982 | 142.338 | 157.743 | 82.537 | 89.76 | 95.876 | 51.532 | 54.261 | 3.229 |
| Non-Current Assets: | |||||||||||||||||
| Property, Plant & Equipment, Net
| 4.289 | 2.084 | 2.513 | 3.041 | 3.481 | 4.07 | 4.594 | 5.224 | 5.824 | 5.745 | 6.291 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0.011 | 0.013 | 0.029 | 0.057 | 0.058 | 0.122 | 0.324 | 0.58 | 0.867 | 1.114 | 1.478 | 0.293 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.14 | 5.704 | 8.92 | 6.951 | 0.504 | 0.465 | 0.504 | 0.455 | 0.442 | 0.375 | 0.36 | 0.344 | 0.293 | 0.293 | 0 | 0.293 | -3.229 |
| Total Non-Current Assets
| 4.429 | 7.788 | 11.433 | 10.003 | 3.998 | 4.564 | 5.155 | 5.737 | 6.388 | 6.444 | 7.231 | 1.211 | 1.407 | 1.771 | 0.293 | 0.293 | -3.229 |
| Total Assets
| 368.56 | 397.291 | 419.356 | 175.546 | 175.618 | 195.178 | 209.604 | 131.435 | 131.37 | 148.782 | 164.974 | 83.748 | 91.167 | 97.647 | 51.825 | 54.554 | 0 |
| Liabilities & Equity: | |||||||||||||||||
| Current Liabilities: | |||||||||||||||||
| Account Payables
| 4.602 | 4.664 | 5.209 | 11.118 | 12.3 | 13.28 | 5.326 | 11.991 | 7.012 | 7.084 | 7.328 | 1.385 | 0.964 | 1.723 | 1.44 | 0.909 | 0 |
| Short Term Debt
| 1.872 | 4.232 | 2.275 | 4.872 | 5.036 | 5.12 | 5.204 | 2.645 | 5.378 | 4.9 | 4.98 | 0 | 0 | 0 | 0 | 0.002 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.45 | 0 | 0 | 0 | 0 | 0 | 0.533 | 0 |
| Other Current Liabilities
| 19.99 | 9.522 | 7.059 | 6.313 | 7.285 | 8.435 | 12.999 | 10.964 | 3.53 | 5.295 | 7.661 | 6.305 | 3.078 | 2.048 | 2.313 | 1.495 | 0 |
| Total Current Liabilities
| 26.464 | 18.418 | 14.543 | 22.303 | 24.621 | 26.835 | 23.529 | 25.6 | 15.92 | 17.279 | 19.969 | 7.69 | 4.042 | 3.771 | 3.753 | 2.406 | 0 |
| Non-Current Liabilities: | |||||||||||||||||
| Long Term Debt
| 53.038 | 50.718 | 50.985 | 51.272 | 27.004 | 27.533 | 28.08 | 28.641 | 9.446 | 9.713 | 10.294 | 4.923 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0.286 | 0.286 | 0.286 | 0.286 | 0.287 | 0.286 | 0.286 | 0.286 | 0.286 | 0.286 | 1.543 | 1.648 | 1.721 | 141.388 | 141.496 | 0 |
| Total Non-Current Liabilities
| 53.038 | 51.004 | 51.271 | 51.558 | 27.29 | 27.82 | 28.366 | 28.927 | 9.732 | 9.999 | 10.58 | 6.466 | 1.648 | 1.721 | 141.388 | 141.496 | 0 |
| Total Liabilities
| 79.502 | 69.422 | 65.814 | 73.861 | 51.911 | 54.655 | 51.895 | 54.527 | 25.652 | 27.278 | 30.549 | 14.156 | 5.69 | 5.492 | 145.141 | 143.902 | 0 |
| Equity: | |||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 91.167 | 97.647 | 139.576 | 139.576 | 40.095 |
| Common Stock
| 0.055 | 0.055 | 0.054 | 0.044 | 0.044 | 0.044 | 0.044 | 0.028 | 0.028 | 0.027 | 0.027 | 0.021 | 0.021 | 0.021 | 0 | 0 | 0 |
| Retained Earnings
| -417.825 | -371.193 | -337.485 | -309.102 | -283.447 | -263.343 | -243.181 | -213.112 | -180.673 | -155.994 | -141.141 | -124.056 | -107.209 | -99.598 | -96.161 | -91.447 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 1.044 | -0.45 | -0.173 | 0.251 | -0.075 | -0.142 | -0.004 | -0.224 | -0.279 | -0.152 | -0.012 | -0 | -91.167 | -97.647 | 0 | 0 | -36.548 |
| Other Total Stockholders Equity
| 705.784 | 699.457 | 691.146 | 410.492 | 407.185 | 403.964 | 400.85 | 290.216 | 286.642 | 277.623 | 275.551 | 193.627 | 283.832 | 191.732 | 2.845 | -137.477 | 0 |
| Total Shareholders Equity
| 289.058 | 327.869 | 353.542 | 101.685 | 123.707 | 140.523 | 157.709 | 76.908 | 105.718 | 121.504 | 134.425 | 69.592 | 85.477 | 92.155 | -93.316 | -89.348 | 3.547 |
| Total Equity
| 289.058 | 327.869 | 353.542 | 101.685 | 123.707 | 140.523 | 157.709 | 76.908 | 105.718 | 121.504 | 134.425 | 69.592 | 85.477 | 92.155 | -93.316 | -89.348 | 3.547 |
| Total Liabilities & Shareholders Equity
| 368.56 | 397.291 | 419.356 | 175.546 | 175.618 | 195.178 | 209.604 | 131.435 | 131.37 | 148.782 | 164.974 | 83.748 | 91.167 | 97.647 | 51.825 | 54.554 | 3.547 |